ASTROTECH Corp Restricted Cash and Cash Equivalents
ASTROTECH Corp (ASTC) had Restricted Cash and Cash Equivalents of $0 as of 2022-03-31, per its 10-Q filed 2022-05-13.
Discontinued › Balance Sheet › Assets
us-gaap:RestrictedCashAndCashEquivalents · last filed 2022-05-13
- 2022-03-31: Restricted Cash and Cash Equivalents $0.00.
- 2021-12-31: Restricted Cash and Cash Equivalents $0.00.
- 2021-03-31: Restricted Cash and Cash Equivalents $542.00K.
- 2021-03-21: Restricted Cash and Cash Equivalents $542.00K.
| Period end | Restricted Cash and Cash Equivalents |
|---|---|
| 2022-03-31 | $0.00 10-Q · filed 2022-05-13 |
| 2021-12-31 | $0.00 10-Q · filed 2022-02-14 |
| 2021-03-31 | $542.00K 10-Q · filed 2021-05-14 |
| 2021-03-21 | $542.00K 10-Q · filed 2022-05-13 |
| 2020-12-31 | $542.00K 10-Q · filed 2022-02-14 |
| 2020-03-31 | $122.00K 10-Q · filed 2021-05-14 |
| 2019-12-31 | $611.00K 10-Q · filed 2021-02-16 |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-14 |
| 2018-12-31 | $0.00 10-Q · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Bionano Genomics, Inc. (BNGO) | United States | $0.020B | -0.42 |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |